Resources
To view these latest guidelines from the Journal of the American Academy of Dermatology, please visit this link: https://www.jaad.org/article/S0190-9622(22)00080-9/fulltext.
The Rapidly Evolving Atopic Dermatitis Treatment Paradigm
Certified for 0.5 CME/CNE/CPE Credit
Click here for more information and to register for this program: http://www.impactedu.net/atopicdermpayertalk/.
Health Plan Best Practices for the Evolving Management of Atopic Dermatitis
Certified for 0.5 CME/CNE/CPE Credit
Register now to participate in this infographic: www.impactedu.net/atopicderminfographic/
Health Plan Best Practices for the Evolving Management of Atopic Dermatitis
For more information and to register for the program: https://www.impactedu.net/atopicdermbestpractices/.
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
https://www.jmcp.org/doi/pdf/10.18553/jmcp.2022.28.1.115
Follow this link from the National Eczema Association to learn more about Eczema Stats: https://nationaleczema.org/research/eczema-facts/
Follow this link to view Case Study 1: www.impactedu.net/adcase1/ .
0.5 CME/CNE/CPE Credits available
Follow this link to view Case Study 2: www.impactedu.net/adcase2/ .
0.5 CME/CNE/CPE Credits available
To view these latest guidelines from the Journal of the American Academy of Dermatology, please visit this link: https://www.jaad.org/article/S0190-9622(22)00080-9/fulltext.
The Rapidly Evolving Atopic Dermatitis Treatment Paradigm
Certified for 0.5 CME/CNE/CPE Credit
Click here for more information and to register for this program: http://www.impactedu.net/atopicdermpayertalk/.
Health Plan Best Practices for the Evolving Management of Atopic Dermatitis
Certified for 0.5 CME/CNE/CPE Credit
Register now to participate in this infographic: www.impactedu.net/atopicderminfographic/
Health Plan Best Practices for the Evolving Management of Atopic Dermatitis
For more information and to register for the program: https://www.impactedu.net/atopicdermbestpractices/.
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
https://www.jmcp.org/doi/pdf/10.18553/jmcp.2022.28.1.115
Follow this link from the National Eczema Association to learn more about Eczema Stats: https://nationaleczema.org/research/eczema-facts/
Follow this link to view Case Study 1: www.impactedu.net/adcase1/ .
0.5 CME/CNE/CPE Credits available
Follow this link to view Case Study 2: www.impactedu.net/adcase2/ .
0.5 CME/CNE/CPE Credits available
The Rapidly Evolving Atopic Dermatitis Treatment Paradigm
Certified for 0.5 CME/CNE/CPE Credit
Click here for more information and to register for this program: http://www.impactedu.net/atopicdermpayertalk/.
Health Plan Best Practices for the Evolving Management of Atopic Dermatitis
Certified for 0.5 CME/CNE/CPE Credit
Register now to participate in this infographic: www.impactedu.net/atopicderminfographic/
Health Plan Best Practices for the Evolving Management of Atopic Dermatitis
For more information and to register for the program: https://www.impactedu.net/atopicdermbestpractices/.
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
https://www.jmcp.org/doi/pdf/10.18553/jmcp.2022.28.1.115
Follow this link from the National Eczema Association to learn more about Eczema Stats: https://nationaleczema.org/research/eczema-facts/
Follow this link to view Case Study 1: www.impactedu.net/adcase1/ .
0.5 CME/CNE/CPE Credits available
Follow this link to view Case Study 2: www.impactedu.net/adcase2/ .
0.5 CME/CNE/CPE Credits available
Health Plan Best Practices for the Evolving Management of Atopic Dermatitis
Certified for 0.5 CME/CNE/CPE Credit
Register now to participate in this infographic: www.impactedu.net/atopicderminfographic/
Health Plan Best Practices for the Evolving Management of Atopic Dermatitis
For more information and to register for the program: https://www.impactedu.net/atopicdermbestpractices/.
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
https://www.jmcp.org/doi/pdf/10.18553/jmcp.2022.28.1.115
Follow this link from the National Eczema Association to learn more about Eczema Stats: https://nationaleczema.org/research/eczema-facts/
Follow this link to view Case Study 1: www.impactedu.net/adcase1/ .
0.5 CME/CNE/CPE Credits available
Follow this link to view Case Study 2: www.impactedu.net/adcase2/ .
0.5 CME/CNE/CPE Credits available
Health Plan Best Practices for the Evolving Management of Atopic Dermatitis
For more information and to register for the program: https://www.impactedu.net/atopicdermbestpractices/.
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
https://www.jmcp.org/doi/pdf/10.18553/jmcp.2022.28.1.115
Follow this link from the National Eczema Association to learn more about Eczema Stats: https://nationaleczema.org/research/eczema-facts/
Follow this link to view Case Study 1: www.impactedu.net/adcase1/ .
0.5 CME/CNE/CPE Credits available
Follow this link to view Case Study 2: www.impactedu.net/adcase2/ .
0.5 CME/CNE/CPE Credits available
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
https://www.jmcp.org/doi/pdf/10.18553/jmcp.2022.28.1.115
Follow this link from the National Eczema Association to learn more about Eczema Stats: https://nationaleczema.org/research/eczema-facts/
Follow this link to view Case Study 1: www.impactedu.net/adcase1/ .
0.5 CME/CNE/CPE Credits available
Follow this link to view Case Study 2: www.impactedu.net/adcase2/ .
0.5 CME/CNE/CPE Credits available
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
https://www.jmcp.org/doi/pdf/10.18553/jmcp.2022.28.1.115
Follow this link from the National Eczema Association to learn more about Eczema Stats: https://nationaleczema.org/research/eczema-facts/
Follow this link to view Case Study 1: www.impactedu.net/adcase1/ .
0.5 CME/CNE/CPE Credits available
Follow this link to view Case Study 2: www.impactedu.net/adcase2/ .
0.5 CME/CNE/CPE Credits available
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
https://www.jmcp.org/doi/pdf/10.18553/jmcp.2022.28.1.115
Follow this link from the National Eczema Association to learn more about Eczema Stats: https://nationaleczema.org/research/eczema-facts/
Follow this link to view Case Study 1: www.impactedu.net/adcase1/ .
0.5 CME/CNE/CPE Credits available
Follow this link to view Case Study 2: www.impactedu.net/adcase2/ .
0.5 CME/CNE/CPE Credits available
Follow this link from the National Eczema Association to learn more about Eczema Stats: https://nationaleczema.org/research/eczema-facts/
Follow this link to view Case Study 1: www.impactedu.net/adcase1/ .
0.5 CME/CNE/CPE Credits available
Follow this link to view Case Study 2: www.impactedu.net/adcase2/ .
0.5 CME/CNE/CPE Credits available
Follow this link to view Case Study 1: www.impactedu.net/adcase1/ .
0.5 CME/CNE/CPE Credits available
Follow this link to view Case Study 2: www.impactedu.net/adcase2/ .
0.5 CME/CNE/CPE Credits available
Follow this link to view Case Study 2: www.impactedu.net/adcase2/ .
0.5 CME/CNE/CPE Credits available